Cover Image
市場調查報告書

藥物遞送用輸液系統的全球市場:醫療設備的開發平台評估

Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 363396
出版日期 內容資訊 英文 148 Pages
訂單完成後即時交付
價格
Back to Top
藥物遞送用輸液系統的全球市場:醫療設備的開發平台評估 Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年07月04日 內容資訊: 英文 148 Pages
簡介

本報告提供全球藥物遞送用輸液設備的市場上之主要開發中產品及其臨床實驗的進展調查,再彙整產品功能·特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 藥物遞送用輸液系統概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:推算各認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 藥物遞送用輸液系統的企業:各臨床實驗階段的開發中產品
  • 藥物遞送用輸液系統:各臨床實驗階段的開發中產品

第5章 藥物遞送用輸液系統市場:企業·產品概要

  • 410 Medical Innovation, LLC
    • 開發中產品及進行中的臨床實驗概要
  • Acuros GmbH
  • AktiVax Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Anesthesia Safety Products, LLC
  • AngioDynamics, Inc.
  • Automedics Medical Systems
  • Baxter International Inc.
  • BioCardia, Inc.
  • Debiotech S.A.
  • Delpor, Inc.
  • Edwards Lifesciences Corporation
  • Eksigent Technologies, LLC
  • Eli Lilly and Company
  • Flowonix Medical, Inc.
  • FluidSynchrony, LLC
  • Fluonic, Inc. Company
  • Fresenius Kidney Care
  • Imagnus Biomedical Inc.
  • Innovfusion Pte. Ltd.
  • Intarcia Therapeutics, Inc.
  • IRadimed Corporation
  • Ivenix, Inc.
  • LifeMedix, LLC
  • Lynntech, Inc.
  • Medallion Therapeutics, Inc.
  • MedPrime Technologies Pvt. Ltd.
  • Mercator MedSystems, Inc.
  • Nano Precision Medical
  • NexGen Medical Systems, Inc.
  • Nipro
  • Owen Mumford Limited
  • Pavmed Inc
  • PRO-IV Medical Ltd.
  • Ratio, Inc.
  • Rice University
  • SteadyMed Therapeutics, Inc.
  • StnDrd Infusion
  • Tel Aviv University
  • Terumo Corporation
  • ToucheMedical Ltd.
  • Unilife Corporation
  • University of Minnesota
  • University of Southern California

第6章 藥物遞送用輸液系統市場:目前的趨勢 (全72件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0209EPD

GlobalData's Medical Devices sector report, "Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Drug Delivery Infusion Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Delivery Infusion Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Drug Delivery Infusion Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Drug Delivery Infusion Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Drug Delivery Infusion Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Drug Delivery Infusion Systems Overview

3. Products under Development

  • 3.1. Drug Delivery Infusion Systems-Pipeline Products by Stage of Development
  • 3.2. Drug Delivery Infusion Systems-Pipeline Products by Segment
  • 3.3. Drug Delivery Infusion Systems-Pipeline Products by Territory
  • 3.4. Drug Delivery Infusion Systems-Pipeline Products by Regulatory Path
  • 3.5. Drug Delivery Infusion Systems-Pipeline Products by Estimated Approval Date
  • 3.6. Drug Delivery Infusion Systems-Ongoing Clinical Trials

4. Drug Delivery Infusion Systems-Pipeline Products under Development by Companies

  • 4.1. Drug Delivery Infusion Systems-Pipeline Products by Stage of Development
  • 4.2. Drug Delivery Infusion Systems-Pipeline Products by Stage of Development

5. Drug Delivery Infusion Systems Companies and Product Overview

  • 5.1. 410 Medical Innovation, LLC Company Overview
    • 5.1.1. 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Acuros GmbH Company Overview
    • 5.2.1. Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. AktiVax Inc. Company Overview
    • 5.3.1. AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Alnylam Pharmaceuticals, Inc. Company Overview
    • 5.4.1. Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Anesthesia Safety Products, LLC Company Overview
    • 5.5.1. Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. AngioDynamics, Inc. Company Overview
    • 5.6.1. AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Automedics Medical Systems Company Overview
    • 5.7.1. Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Baxter International Inc. Company Overview
    • 5.8.1. Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. BioCardia, Inc. Company Overview
    • 5.9.1. BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Debiotech S.A. Company Overview
    • 5.10.1. Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Delpor, Inc. Company Overview
    • 5.11.1. Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Edwards Lifesciences Corporation Company Overview
    • 5.12.1. Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Eksigent Technologies, LLC Company Overview
    • 5.13.1. Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Eli Lilly and Company Company Overview
    • 5.14.1. Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Flowonix Medical, Inc. Company Overview
    • 5.15.1. Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. FluidSynchrony, LLC Company Overview
    • 5.16.1. FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Fluonic, Inc. Company Overview
    • 5.17.1. Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Fresenius Kidney Care Company Overview
    • 5.18.1. Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Imagnus Biomedical Inc. Company Overview
    • 5.19.1. Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Innovfusion Pte. Ltd. Company Overview
    • 5.20.1. Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Intarcia Therapeutics, Inc. Company Overview
    • 5.21.1. Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. IRadimed Corporation Company Overview
    • 5.22.1. IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Ivenix, Inc. Company Overview
    • 5.23.1. Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. LifeMedix, LLC Company Overview
    • 5.24.1. LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Lynntech, Inc. Company Overview
    • 5.25.1. Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Medallion Therapeutics, Inc. Company Overview
    • 5.26.1. Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Medical Device Creations Ltd. Company Overview
    • 5.27.1. Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. MedPrime Technologies Pvt. Ltd. Company Overview
    • 5.28.1. MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Mercator MedSystems, Inc. Company Overview
    • 5.29.1. Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Nano Precision Medical Company Overview
    • 5.30.1. Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. NexGen Medical Systems, Inc. Company Overview
    • 5.31.1. NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Nipro Corporation Company Overview
    • 5.32.1. Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Owen Mumford Limited Company Overview
    • 5.33.1. Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Pavmed Inc Company Overview
    • 5.34.1. Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. PRO-IV Medical Ltd. Company Overview
    • 5.35.1. PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Ratio, Inc. Company Overview
    • 5.36.1. Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Rice University Company Overview
    • 5.37.1. Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. SteadyMed Therapeutics, Inc. Company Overview
    • 5.38.1. SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. StnDrd Infusion Corporation Company Overview
    • 5.39.1. StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Tel Aviv University Company Overview
    • 5.40.1. Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Terumo Corporation Company Overview
    • 5.41.1. Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. ToucheMedical Ltd. Company Overview
    • 5.42.1. ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Unilife Corporation Company Overview
    • 5.43.1. Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. University of Minnesota Company Overview
    • 5.44.1. University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. University of Southern California Company Overview
    • 5.45.1. University of Southern California Pipeline Products & Ongoing Clinical Trials Overview

6. Drug Delivery Infusion Systems-Recent Developments

  • 6.1. Jun 16, 2016: Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate within the First Month of Implementation
  • 6.2. Jun 14, 2016: IRADIMED Announces Election of Roger Susi as Chairman of the Board
  • 6.3. Jun 13, 2016: Aarti Shah named chief information officer
  • 6.4. Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions
  • 6.5. Jun 09, 2016: IRADIMED Provides Regulatory Update
  • 6.6. Jun 07, 2016: Intarcia Announces Branding of the Medici Drug Delivery System- A Platform of Technologies Key to Advancing its Pipeline of Once-Yearly Peptide and Antibody Fragment-Based Therapeutics in Poorly Controlled Chronic Diseases
  • 6.7. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.8. Jun 03, 2016: Autostart Burette Listed Through Qld Health Tender
  • 6.9. Jun 01, 2016: Phillips-Medisize Acquires Medicom Innovation Partner
  • 6.10. Jun 01, 2016: Flowonix Medical Raises USD10.5 Million in Venture Financing
  • 6.11. Jun 01, 2016: Flowonix Medical Secures USD5 Million in Venture Debt Financing
  • 6.12. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.13. May 24, 2016: Pyng Medical Reports Second Quarter Fiscal 2016 Results
  • 6.14. May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community
  • 6.15. May 23, 2016: Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision With Iluvien At 12 Months
  • 6.16. May 23, 2016: Unilife Announces Receipt of Deficiency Letter from NASDAQ
  • 6.17. May 18, 2016: Study Finds 90 Percent of Pump Programming Events for High-Alert Infusion Medications are Dose Adjustments
  • 6.18. May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO
  • 6.19. May 18, 2016: Repro Med Systems Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors
  • 6.20. May 16, 2016: B. Braun to Showcase Its Innovative Synchronized Intelligence Infusion Platform at AACN
  • 6.21. May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO
  • 6.22. May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results
  • 6.23. May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026
  • 6.24. May 11, 2016: Steadymed Provides Corporate Update And Reports First Quarter 2016 Financial Results
  • 6.25. May 10, 2016: B. Braun Medical Calls for ECRI Institute to Establish a Scientific, Protocol-Driven Methodology for Evaluating Infusion Pumps
  • 6.26. May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference
  • 6.27. May 06, 2016: Alimera Sciences' ILUVIEN Data Presented At 2016 ARVO
  • 6.28. May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes
  • 6.29. May 03, 2016: Strong start into the year-Double-digit earnings growth in constant currency-Fresenius confirms Group guidance for 2016
  • 6.30. Apr 29, 2016: IRADIMED Announces First Quarter 2016 Financial Results
  • 6.31. Apr 15, 2016: InfuSystem to Acquire Infusion Pump Assets from InfusAID
  • 6.32. Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building
  • 6.33. Apr 01, 2016: IRADIMED Provides Regulatory Update
  • 6.34. Mar 29, 2016: Hicks Thomas Represents EMED Technologies Seeking Injunction against RMS Medical Products for Infusion Devices FDA Warns Are Adulterated and Misbranded
  • 6.35. Mar 15, 2016: Zyno Medical to Feature Z-800F Set Based Anti-Free-Flow IV Pump at NHIA
  • 6.36. Mar 09, 2016: Repro Med Systems Responds to FDA Warning Letter
  • 6.37. Feb 26, 2016: Zyno Medical to Feature ZynoFlo Integrated Infusion System at ACCC
  • 6.38. Feb 26, 2016: Zyno Medical to Feature Z-800WF IV Infusion Pump at ACCC
  • 6.39. Feb 24, 2016: Alaris System Named 2015 Best In KLAS for Smart Pumps
  • 6.40. Feb 24, 2016: Outstanding 2015 financial results-25% dividend increase proposed-Positive outlook for 2016-New mid-term growth targets
  • 6.41. Feb 24, 2016: Aetna and Roxborough Memorial Hospital Agree to Three-Year Contract
  • 6.42. Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director
  • 6.43. Feb 05, 2016: IRADIMED Announces Fourth Quarter 2015 Financial Results
  • 6.44. Jan 21, 2016: Mercator MedSystems Announces First Patient Enrolled in Below the Knee Clinical Trial
  • 6.45. Jan 20, 2016: LifeFlow Rapid Infuser Receives Innovation Award at Pediatrics 2040 Meeting
  • 6.46. Jan 13, 2016: Pfizer May Sell Infusion Pump Business of Hospira
  • 6.47. Jan 11, 2016: IRADIMED Announces 2016 Annual and First Quarter Financial Guidance
  • 6.48. Jan 06, 2016: Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer
  • 6.49. Dec 10, 2015: IRADIMED Updates Status of 510(k) Submission
  • 6.50. Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing
  • 6.51. Nov 05, 2015: Surefire Medical Raises Additional USD4 Million in Venture Financing
  • 6.52. Nov 03, 2015: IRadimed Plans to Raise up to USD40 Million in Public Offering of Shares
  • 6.53. Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT
  • 6.54. Oct 30, 2015: IRADIMED Announces Third Quarter 2015 Financial Results
  • 6.55. Oct 30, 2015: IRADIMED Announces Dismissal of Appeal
  • 6.56. Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting
  • 6.57. Oct 23, 2015: Edwards Lifesciences Enters into Agreement with CareFusion
  • 6.58. Oct 08, 2015: Smiths Medical Awarded Contract by Novation
  • 6.59. Oct 08, 2015: Bespak Launches New Brand Identity To The Market
  • 6.60. Oct 05, 2015: Medicom receives the growth award-Borsen Gazelle 2015
  • 6.61. Sep 25, 2015: Surefire Medical Introduces New Precision Infusion System
  • 6.62. Sep 22, 2015: B. Braun Receives FDA Clearance for Infusomat Space Pump
  • 6.63. Sep 03, 2015: pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation's BioInterface 2015 Annual Symposium
  • 6.64. Sep 01, 2015: Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device
  • 6.65. Aug 27, 2015: Hospira Announces First Installation of Plum 360 Infusion System With Hospira MedNet
  • 6.66. Aug 11, 2015: Command Medical Products Announces Promotion to Vice President
  • 6.67. Jul 31, 2015: Symbiq Infusion System by Hospira: FDA Safety Communication-Cybersecurity Vulnerabilities
  • 6.68. Jul 30, 2015: IRADIMED Announces Second Quarter 2015 Financial Results
  • 6.69. Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results
  • 6.70. Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015
  • 6.71. Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders
  • 6.72. Jul 08, 2015: MicroPort Lifesciences Attends Diabetes and Gonadal Disorders Meeting to Promote La Fenice

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
  • Table 2: Drug Delivery Infusion Systems - Pipeline Products by Segment
  • Table 3: Drug Delivery Infusion Systems - Pipeline Products by Territory
  • Table 4: Drug Delivery Infusion Systems - Pipeline Products by Regulatory Path
  • Table 5: Drug Delivery Infusion Systems - Pipeline Products by Estimated Approval Date
  • Table 6: Drug Delivery Infusion Systems - Ongoing Clinical Trials
  • Table 7: Drug Delivery Infusion Systems Companies - Pipeline Products by Stage of Development
  • Table 8: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
  • Table 9: 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: LifeFlow Rapid Infusion System - Product Status
  • Table 11: LifeFlow Rapid Infusion System - Product Description
  • Table 12: Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Disposable Micropump - Product Status
  • Table 14: Disposable Micropump - Product Description
  • Table 15: AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Immunoject - Product Status
  • Table 17: Immunoject - Product Description
  • Table 18: Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: ALN-HTT Infusion System - Product Status
  • Table 20: ALN-HTT Infusion System - Product Description
  • Table 21: Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: FloStat Infusion Pump System - Product Status
  • Table 23: FloStat Infusion Pump System - Product Description
  • Table 24: AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: BioFlo Portline Line Extension - Product Status
  • Table 26: BioFlo Portline Line Extension - Product Description
  • Table 27: Next Generation BioFlo Port - Product Status
  • Table 28: Next Generation BioFlo Port - Product Description
  • Table 29: Power Injectable Port - Product Status
  • Table 30: Power Injectable Port - Product Description
  • Table 31: Smart Port - Dual - Product Status
  • Table 32: Smart Port - Dual - Product Description
  • Table 33: Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: AutoHep System - Product Status
  • Table 35: AutoHep System - Product Description
  • Table 36: Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Infusion Pump - Product Status
  • Table 38: Infusion Pump - Product Description
  • Table 39: BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Helix Transendocardial Delivery System - Product Status
  • Table 41: Helix Transendocardial Delivery System - Product Description
  • Table 42: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: MIP Device - Product Status
  • Table 44: MIP Device - Product Description
  • Table 45: Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Delpor Microfabricated Nanopore Device - Product Status
  • Table 47: Delpor Microfabricated Nanopore Device - Product Description
  • Table 48: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Integrated Semi-Closed Loop System - Product Status
  • Table 50: Integrated Semi-Closed Loop System - Product Description
  • Table 51: Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: External Drug Delivery System - Product Status
  • Table 53: External Drug Delivery System - Product Description
  • Table 54: Implantable Drug Delivery System - Product Status
  • Table 55: Implantable Drug Delivery System - Product Description
  • Table 56: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Drug Delivery System - Parkinson's Disease - Product Status
  • Table 58: Drug Delivery System - Parkinson's Disease - Product Description
  • Table 59: Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Implanted Drug Delivery System - Product Status
  • Table 61: Implanted Drug Delivery System - Product Description
  • Table 62: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: FluidSync Pump - Product Status
  • Table 64: FluidSync Pump - Product Description
  • Table 65: Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: SURE+ - Product Status
  • Table 67: SURE+ - Product Description
  • Table 68: Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Intravenous 2008MeDS - Product Status
  • Table 70: Intravenous 2008MeDS - Product Description
  • Table 71: Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: DeltaFlow Infusion Regulator - Product Status
  • Table 73: DeltaFlow Infusion Regulator - Product Description
  • Table 74: Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 75: DIVA - Product Status
  • Table 76: DIVA - Product Description
  • Table 77: EPIVA - Product Status
  • Table 78: EPIVA - Product Description
  • Table 79: INTRAVA - Product Status
  • Table 80: INTRAVA - Product Description
  • Table 81: Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: ITCA 638 - Product Status
  • Table 83: ITCA 638 - Product Description
  • Table 84: ITCA 650 Osmotic Pump - Product Status
  • Table 85: ITCA 650 Osmotic Pump - Product Description
  • Table 86: ITCA 880 - Product Status
  • Table 87: ITCA 880 - Product Description
  • Table 88: IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: MRidium 3860+ MRI IV Pump - Product Status
  • Table 90: MRidium 3860+ MRI IV Pump - Product Description
  • Table 91: Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Next-Generation Infusion Management System - Product Status
  • Table 93: Next-Generation Infusion Management System - Product Description
  • Table 94: LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: STATfusion - Product Status
  • Table 96: STATfusion - Product Description
  • Table 97: Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: Disposable Drug Infusion Pump - Product Status
  • Table 99: Disposable Drug Infusion Pump - Product Description
  • Table 100: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: Medallion Infusion System - Product Status
  • Table 102: Medallion Infusion System - Product Description
  • Table 103: Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: Infusion Pump - Product Status
  • Table 105: Infusion Pump - Product Description
  • Table 106: MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: InfuCheck - Product Status
  • Table 108: InfuCheck - Product Description
  • Table 109: Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Bullfrog Micro-Infusion Device - Below The Knee - Product Status
  • Table 111: Bullfrog Micro-Infusion Device - Below The Knee - Product Description
  • Table 112: Mercator MedSystems, Inc. - Ongoing Clinical Trials Overview
  • Table 113: Bullfrog Micro-Infusion Device - Below The Knee - Lower-limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-based Revascularization (LIMBO-ATX)
  • Table 114: Bullfrog Micro-Infusion Device - Below The Knee - Lower-limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis after Percutaneous Transluminal Angioplasty Revascularization (LIMBO-PTA)
  • Table 115: Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Nano Portal Capsule - Product Status
  • Table 117: Nano Portal Capsule - Product Description
  • Table 118: NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: PeriCATH - Product Status
  • Table 120: PeriCATH - Product Description
  • Table 121: Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 122: Pump For Venous Anesthesia Infusion - Product Status
  • Table 123: Pump For Venous Anesthesia Infusion - Product Description
  • Table 124: Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: UniSafe - Product Status
  • Table 126: UniSafe - Product Description
  • Table 127: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 128: NextFlo - Product Status
  • Table 129: NextFlo - Product Description
  • Table 130: PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 131: Drop Controlling/Counting Valve - Product Status
  • Table 132: Drop Controlling/Counting Valve - Product Description
  • Table 133: Drug Port Verification Valve - Product Status
  • Table 134: Drug Port Verification Valve - Product Description
  • Table 135: Electronic Valve - Product Status
  • Table 136: Electronic Valve - Product Description
  • Table 137: PRIDE System - Product Status
  • Table 138: PRIDE System - Product Description
  • Table 139: Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 140: NuPrivo - CI - Product Status
  • Table 141: NuPrivo - CI - Product Description
  • Table 142: Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 143: AutoSyP Syringe Pump - Product Status
  • Table 144: AutoSyP Syringe Pump - Product Description
  • Table 145: SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 146: PatchPump - Product Status
  • Table 147: PatchPump - Product Description
  • Table 148: StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 149: Smart Infusion System - Product Status
  • Table 150: Smart Infusion System - Product Description
  • Table 151: StnDrd Pump - Product Status
  • Table 152: StnDrd Pump - Product Description
  • Table 153: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 154: Short Peripheral Infusion Catheter - Product Status
  • Table 155: Short Peripheral Infusion Catheter - Product Description
  • Table 156: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 157: Needleless Infusion System - Product Status
  • Table 158: Needleless Infusion System - Product Description
  • Table 159: Terufusion - Product Status
  • Table 160: Terufusion - Product Description
  • Table 161: ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 162: Syringe Based Patch Pump - Product Status
  • Table 163: Syringe Based Patch Pump - Product Description
  • Table 164: Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 165: Unilife AutoInfusor - Product Status
  • Table 166: Unilife AutoInfusor - Product Description
  • Table 167: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • Table 168: Infusion Micropump - Product Status
  • Table 169: Infusion Micropump - Product Description
  • Table 170: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
  • Table 171: Drug Infusion Pump - Product Status
  • Table 172: Drug Infusion Pump - Product Description
  • Table 173: Glossary

List of Figures

  • Figure 1: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development
  • Figure 2: Drug Delivery Infusion Systems - Pipeline Products by Segment
  • Figure 3: Drug Delivery Infusion Systems - Pipeline Products by Territory
  • Figure 4: Drug Delivery Infusion Systems - Pipeline Products by Regulatory Path
  • Figure 5: Drug Delivery Infusion Systems - Pipeline Products by Estimated Approval Date
  • Figure 6: Drug Delivery Infusion Systems - Ongoing Clinical Trials
Back to Top